Professional journals serve as critical avenues to promote communication of new research findings and syntheses of scientific information throughout the medical community. There can be a delay, however, in the application of such scientific information to actual clinical practice. In the field of integrative cancer care, this normal delay is complicated by the implementation of many techniques of alternative, complementary, and traditional medicine before scientific validation. Both of these patterns can leave the practitioner scrambling to understand new trends in the field. To begin to address the problem of advancing clinical practice and understanding in integrative cancer care, this journal is offering an article series that we call the Integrative Tumor Board.
The Integrative Tumor Board in Integrative Cancer Therapies is a forum unique among journal-based tumor boards. It is modeled on the activities of a hospital tumor board but is based on an integrative cancer medicine perspective. In typical tumor boards, a physician will present standard clinical data on a case, and several medical specialists will then comment on the case from their own perspectives. The unique feature of the Integrative Tumor Board is that in addition to comments from medical specialists, practitioners of a variety of complementary, alternative, and integrative disciplines will also give their analyses of each case. Final comments will be made at the end of the practitioner contributions, pointing out particularly interesting features or raising issues or concerns; comments are supervised by the journal's editor-in-chief in consultation with experts in several relevant disciplines. Integrative Tumor Boards will be presented in most or all issues of Integrative Cancer Therapies; they will be composed of recommendations of rotating panels of medical specialists and other practitioners.
It is important that the reader understand some of the basic premises of the Integrative Tumor Board: are not presented as an example of how patients should be treated from an integrative medicine perspective. Actual treatment at an integrative clinic requires regular interaction and exchange among the cooperating practitioners and overall supervision by a physician who is aware of the potential contributions of the various disciplines represented in the clinic. The Integrative Tumor Board is, rather, a venue to present perspectives of a variety of disciplines important in integrative cancer care in a public forum. Its purpose is to promote knowledge and understanding of these perspectives by all health professionals working with cancer patients, since the majority of cancer patients currently are taking advantage of 1 or more integrative therapies. We will try to encourage important areas of synergy and point out potential negative interactions (eg, drug-herb interactions), recognizing that adequate management of both is fundamental to truly integrative care. However, this is not easily accomplished when practiced within a single facility, let alone when bringing together many modalities from several different practitioners. Still, we will attempt to address as best we can the more relevant interrelationships.
Not all of the suggestions made in Integrative Tumor
Board articles will be solidly evidence based, particularly since some aspects of integrative care fall into a category one might call intangibles. Still, we are encouraging integrative practitioners to make an attempt to anchor suggestions in scientific evidence, or at least to submit suggestions that are not unreasonable from a scientific or psychological viewpoint, or from a traditional medicine perspective in the articles submitted by practitioners from various schools of traditional medicine. 4. We expect that the many evidence-based or scientifically reasonable suggestions in Integrative Tumor Board articles will be viewed with seriousness even by readers accustomed to working in a conventional medicine perspective. Such readers may be startled, however, by some of the less evidence-based suggestions, or by the spiritual counseling that will be offered by some practitioners. Conventionally oriented health professionals should realize that their cancer patients may indeed be seeing practitioners who work from less evidence-based perspectives. We strongly feel both that this is a relevant aspect of integrative care and that it is important that health professionals understand the nature of such perspectives, and some of the potentially healthful (or unhealthful) practices they prescribe. This is essential information for those electing to work constructively with patients who are using practices of alternative, complementary, and traditional medicine in coping with their illnesses. 5. As will become evident in the Case Presentation, the information given to contributing practitioners is the clinical data obtained before counseling the patient on an integrative intervention. The initial case also may include information on lifestyle and psychosocial issues of the patient taken from a comprehensive questionnaire administered at the clinic of the presenting physician; details of some of this information from the actual patient, or the clinical information, may be changed to enable a clearer and more focused discussion or to promote elaboration of certain issues. Many laboratory analyses, and all traditional medicine diagnostic techniques, are absent from the presentation. This limits the ability of practitioners to make specific recommendations for the patient, as several have noted. In response, however, most of the practitioners have made their own recommendations for laboratory analyses and other diagnostic techniques. In these recommendations, one can perceive the types of clinical analysis used in each discipline included in the Integrative Tumor Boardinformation that is surely as useful as specific clinical suggestions in developing an understanding of integrative approaches to cancer.
Many readers will find the volume of information included in the Tumor Board articles overwhelming. This reaction is, in fact, typical of those attending hospital tumor boards as well. We also feel that it is true that integrative care itself can seem overwhelming to both practitioners and patients, particularly those just beginning their encounters with the field. This is not an irrelevant issue when working with patients already facing circumstances surrounding their illness and treatments that are burdensome in and of themselves. As we have found in patient care, and as we trust will occur with those of you new to integrative cancer treatment, you will become more familiar with the various practices that will be included in the Integrative Tumor Board, and this sense of being submerged in information will diminish. We hope that the Tumor Board series will advance comprehension of both the conventional medical interventions and the complementary, alternative, and traditional medicine interventions on the part of health professionals and patients as this new approach to cancer care grows and develops.
Case Presentation History
Chief complaint: Elevated prostate-specific antigen
History of present illness:
The patient is a 67-yearold white man, born in Bucharest, Romania. He is referred for evaluation of a prostate-specific antigen (PSA) value of 4.64 found in the course of a routine physical examination by his primary care physician. The patient has not had a previous PSA examination. He reports urinary frequency every 4 to 6 hours, with nocturia between 0 and 2 times per night. He denies a history of dysuria, hematuria, or urgency. He reports occasional hesitancy but states the quality of his stream is "good" 90% of the time he voids.
Abdomen:
The abdomen was soft, nontender, with no evidence of hepatosplenomegaly.
Penis:
The penis was circumcised, without skin lesions.
Testes:
The testes were descended bilaterally, with normal texture and epididymes bilaterally.
Prostate:
The prostate was asymmetric, with the left lobe measuring 3 cm in height and the right lobe 3.5 cm in height. The width was 3.5 cm. The texture was 1 out of 3 plus indurated; the landmarks were intact and no seminal vesicles could be palpated.
Rectal: Rectal tone was intact and no masses were palpable.
Impression
The patient is a 67-year-white man with an elevated PSA of 4.64 and an asymmetric prostate gland on examination.
Plan
A urine sample for urinalysis and culture was obtained. It was recommended that the patient undergo a transrectal ultrasound of the prostate with ultrasonographically guided systematic prostate biopsies. The procedure was discussed, and the risks of bleeding, infection, and pain reviewed. The patient and his wife agreed to the recommendation.
Course
Five days after his initial visit, the patient underwent transrectal ultrasonography of the prostate with guided systematic biopsies. A total of 10 biopsy specimens were sent. Pathological examination demonstrated Gleason's score 3+3 and moderately differentiated adenocarcinoma with no perineural invasion in approximately 25% of the tissue. The patient was informed of his diagnosis, and a counseling session was arranged with him and his wife. Treatment options, including radical prostatectomy, radiation therapy (external beam, brachytherapy, or combination of the two), watchful waiting, hormonal manipulation, cryotherapy, hyperthermia, and focused energy, were reviewed. The relative risks and merits of each approach were discussed. In light of the patient's age and overall health status, it was recommended he consider either surgery or radiation. The patient elected to undergo brachytherapy, and he was referred to the radiation oncologist for evaluation. It was felt that the success of the brachytherapy would be enhanced with a reduction in his prostate volume. Toward that end, the patient was started on Casodex 50 mg po daily for 2 weeks, followed by an injection of leuprolide acetate 30 mg. He is currently awaiting reimaging of his prostatic volume in approximately 6 weeks to see whether we can proceed to radioactive seed implantation at that time.
Social History
Born in Romania; has 2 sisters, 1 deceased. Immigrated to the United States in 1949. Has worked as a cabinet maker, shipping clerk, tile setter, deputy sheriff, and currently is a retired building inspector. Received BS degree from a Chicago-area educational institution. Married 48 years; 2 children and 7 grandchildren. His wife has attended all clinic visits. Many hobbies, including skeet shooting, in which he has competed internationally. Has been active in local politics. The patient and his wife eat a typical American diet. The patient appears anxious, with a tense affect and a high level of energy. He appears to be in some denial about the disease and avoids discussing it more than necessary. There has been substantial stress in the family about the choice of initial treatment (brachytherapy or surgery). 
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